Daniel Francon
Papers
1
Total Citations
34
H-Index
1
About
Daniel Francon is a leading gynecologic oncologist whose research focuses on optimizing surgical outcomes in women with gynecologic cancers, with a particular emphasis on comparing robotic-assisted and conventional laparoscopic techniques. His most impactful contribution is the landmark ROBOGYN-1004 randomized controlled trial, which systematically evaluated severe perioperative morbidity between these two minimally invasive approaches. This pivotal study, published in 2020 and cited 34 times, provided critical evidence that robot-assisted laparoscopy does not significantly reduce major complications compared to conventional laparoscopy, challenging prevailing assumptions and guiding clinical decision-making. Francon’s work has been instrumental in refining surgical protocols, emphasizing patient safety, and promoting evidence-based adoption of robotic technology in gynecologic oncology. His research addresses a key question in the field: whether the substantial costs of robotic systems translate into tangible benefits for patients. By delivering rigorous, randomized data, Francon has helped shape international guidelines and sparked ongoing debate about the value of surgical innovation. His contributions are essential reading for surgeons and researchers seeking to balance technological advancement with proven clinical outcomes.
Research Focus
Key Achievements
Top Papers
- 1